Hemab Therapeutics Holdings, Inc. (COAG)

Hemab Therapeutics Holdings will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

COAG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.01	-0.01	-0.01
Debt / EBITDA Ratio	-0.02	-0.02	-0.03
Debt / FCF Ratio	-0.02	-0.02	-0.04
Net Debt / Equity Ratio	1.04	1.04	0.75
Net Debt / EBITDA Ratio	2.80	2.80	1.66
Net Debt / FCF Ratio	3.00	3.00	1.89
Quick Ratio	17.37	17.37	13.21
Return on Equity (ROE)	36.18%	36.18%	42.25%
Return on Assets (ROA)	-32.81%	-32.81%	-50.59%
Return on Capital Employed (ROCE)	-35.91%	-35.91%	-58.33%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).